IFRX logo

InflaRx N.V. Common Stock

IFRX

IFRX: InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its lead product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

more

Show IFRX Financials

All
Government
Consumer Interest
SEC Filings
ESG/Other

Recent trades of IFRX by members of U.S. Congress

  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
Quiver Logo

Sign Up for Access

Sign Up or Login

Recently reported changes by institutional investors

Quiver Logo

Sign Up for Access

Sign Up or Login

Quarterly net insider trading by IFRX's directors and management

Quiver Logo

Sign Up for Access

Sign Up or Login

Government lobbying spending instances

  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
Quiver Logo

Sign Up for Access

Sign Up or Login
U.S. Patents

New patents grants

  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
Quiver Logo

Sign Up for Access

Sign Up or Login
Government Contracts

Federal grants, loans, and purchases

  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
Quiver Logo

Sign Up for Access

Sign Up or Login
WallStreetBets

Number of mentions of IFRX in WallStreetBets Daily Discussion

Quiver Logo

Sign Up for Access

Sign Up or Login
IFRX News

Recent insights relating to IFRX

  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
Quiver Logo

Sign Up for Access

Sign Up or Login
CNBC Recommendations

Recent picks made for IFRX stock on CNBC

  • Pick: Hidden Pick Title Hidden Date
  • Pick: Hidden Pick Title Hidden Date
  • Pick: Hidden Pick Title Hidden Date
  • Pick: Hidden Pick Title Hidden Date
  • Pick: Hidden Pick Title Hidden Date
Quiver Logo

Sign Up for Access

Sign Up or Login
Top ETF Holders

ETFs with the largest estimated holdings in IFRX

  • ETF: Hidden ETF Title Hidden Date
  • ETF: Hidden ETF Title Hidden Date
  • ETF: Hidden ETF Title Hidden Date
  • ETF: Hidden ETF Title Hidden Date
  • ETF: Hidden ETF Title Hidden Date
Quiver Logo

Sign Up for Access

Sign Up or Login
Corporate Flights

Flights by private jets registered to IFRX

  • Flight Title: Hidden Quiver Flight Title Hidden Date
  • Flight Title: Hidden Quiver Flight Title Hidden Date
  • Flight Title: Hidden Quiver Flight Title Hidden Date
  • Flight Title: Hidden Quiver Flight Title Hidden Date
  • Flight Title: Hidden Quiver Flight Title Hidden Date
Quiver Logo

Sign Up for Access

Sign Up or Login